Chapter 127 Dr. Charpentier and Dr. Doudna are stunned

They didn’t expect that Lin Feng would suddenly come to them. This was really a novel thing.

Out of curiosity, they looked at the mobile phones in their hands, and then saw the screen image suddenly changed.

"Good morning, doctors."

Because the earth is a sphere, when it is afternoon in Daxia, it is 9 a.m. in Deyizhi.

"Hello Mr. Lin Feng, I didn't expect that we would meet in this way."

Dr. Doudna took the initiative to say hello.

"There is no other way. Time is urgent."

Lin Feng spread his hands with a helpless expression.

At this moment, he was looking at the two middle-aged women opposite him with deep emotion, because the two female doctors in front of him were the future winners of the 2020 Nobel Prize.

They relied on the CRISPR/Cas9 gene editing technology they invented, although they are the biggest contributors to CRISPR/Cas9 gene editing technology.

It must be Dr. Zhang Feng from the Broad Institute of Harvard University in the United States.

After all, he had achieved too many scientific research results in CRISPR/Cas9 gene editing technology in his previous life, far surpassing Dr. Doudna and Dr. Charpentier, the inventors of CRISPR/Cas9 gene editing technology.

But when it comes to invention awards, it ultimately depends on who invented the technology first, not who significantly improved the technology.

"Mr. Lin Feng, I wonder what you want to talk to us about?"

Dr. Charpentier asked about Lin Feng curiously.

"I wonder if you have heard about the fact that I founded Xingtu Gene Company yesterday?"

Instead, Raymond Lam asked about the two female doctors.

In response to this, the two female doctors looked confused, and it was obvious that they had no idea that Xingtu Gene Company had been established.

In response, Lin Feng nodded in understanding.

Speaking of which, the fact that Xingtu Technology established Xingtu Gene Company and spent 200 billion Xia yuan to build a laboratory alone has caused a lot of heated discussion.

But the news in Daxia and the news abroad and even the Internet are actually two different worlds, so it is normal that there is a big commotion in Daxia but no big commotion overseas.

Of course, the report was definitely reported by the media, but it was obviously not reported in the form of core news, but in the form of side information, so it is normal that the two female doctors did not know about it.

"Since you two don't know, let me give you a brief introduction."

After a pause, Lin Feng continued:

“I am serious about genetic research and development, so I directly spent $32 billion to build a genetic research and development laboratory.

Next, I also plan to spend a large sum of money to acquire the technical license or buyout license for CRISPR/Cas9 gene editing technology.

Because I want CRISPR/Cas9 gene editing technology to realize the dream of immortality and solving human diseases. "

"A $32 billion genetic research and development laboratory?!"

Doudna exclaimed, her eyes wide open with shock written all over them.

Although $32 billion may not seem like a large amount, it is a huge sum of money, and it is also a number that drives many large companies crazy.

After all, it is 2015 now, and the inflation of the US dollar has not reached the exaggerated level it will be nine years later, so 9 billion US dollars is a very large number.

For many companies, even making hundreds of millions of dollars a year, let alone $32 billion, would be enough to be praised and proud.

But at this time, Lin Feng directly took out 32 billion US dollars to build a genetic laboratory. Is this too crazy? Is this too much money?

"It is indeed 32 billion US dollars." Lin Feng nodded, then said with a smile:

“Of course, this $32 billion is not the end, in fact I will continue to invest money in the future.

So the $32 billion is just the investment for building the laboratory. It is estimated that no less than $15 billion will be invested in genetic research and development each year.

In short, no matter how much money you make, it is just a bunch of numbers. Keeping it will only make the bank cheaper, so I am willing to spend money and I am determined to spend money. "

"This……"

Faced with Lin Feng's heroic words, Dr. Charpentier and Dr. Doudna didn't know what to say.

Look, is this what people say?
Money is just a bunch of numbers. Is this statement too pretentious?

Of course, although they secretly criticized Raymond Lam’s flaunting of wealth, deep down they really liked listening to what Raymond Lam said.

Because R&D investors like Lin Feng are the type that all scientific researchers like and love the most.

However, the things that shocked them did not stop there. Lin Feng on the phone screen continued:

“I am investing $32 billion to build a genetic research laboratory, and in addition to purchasing a large number of high-tech scientific research instruments.

Legless wheeled robots will also be used on a large scale, and these legless wheeled robots will be fully controlled by the artificial intelligence Jarvis.

Although it does not have a humanoid head and thighs, it has two Xingtu Z1 robotic arms with ultra-high control precision.

With the control accuracy of the Xingtu Z1 robotic arm reaching 0.01mm to 0.02mm.

We can use it to replace a large number of basic experimental personnel, thereby conducting high-intensity, uninterrupted, ultra-large-scale synchronous experiments.

From now on, except for a very small number of genetic experiments, all other experiments can be handed over to the artificial intelligence Jarvis and the legless wheeled robots.

Researchers only need to come up with new technology development directions and new theories based on genetic experimental data, which greatly speeds up research and development.”

When Lin Feng finished speaking, a promotional video of Xingtu Gene Company produced by artificial intelligence Jarvis and Chen Hang appeared on the mobile phone screen.

In this promotional video, you can clearly see countless robots busy working in the bright white laboratory.

The researchers, on the other hand, sit in front of their computers to check various experimental data or hold small meetings for discussions.

Of course, the screen also shows the artificial intelligence Jarvis using big data to analyze the differences in the characteristics of certain gene fragments, assisting researchers in genetic research and development.

After seeing this promotional video, the two female doctors, Charpentier and Doudna, could not help but be a little dazed, because this scene was too tempting for scientific researchers.

“Two doctors, our genetic research and development laboratory at Xingtu Genetics is currently in its infancy, and we are in great need of top genetics doctors to join us.

If you join our Xingtu Gene Research and Development Laboratory, I can give you three times your original annual salary!
As for exclusive research funding, each of you can have $2 million in research project funding support every year!"

After hearing Lin Feng's words, Dr. Charpentier and Dr. Doudna were stunned again, shocked by Lin Feng's generosity.

Because this is really too crazy. Xingtu Gene Company is willing to give each of them US$2 million in scientific research project funds every year. Is this salary too high?

Faced with such high salaries from Starway Genetics, the two doctors really couldn’t refuse.

After all, for a scientific researcher, after satisfying his living wage, the only pleasure is to do research and development.

However, research and development requires huge scientific research funds. At this time, Lin Feng is willing to provide each person with US$2 million in research and development funds each year, which they really cannot refuse.

But this is not something they can decide easily.

Although they are the inventors of the CRISPR/Cas9 gene editing technology, the technical patent results must also be shared with the Max Planck Institute.

After all, the Max Planck Institute provides you with space, equipment, and R&D funding. They naturally cannot be a good guy and must share the maximum benefits of the patent.

(End of this chapter)